
Euroespes SA
MAD:EEP

Operating Margin
Euroespes SA
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | Company | Market Cap |
Operating Margin |
||
---|---|---|---|---|---|
ES |
![]() |
Euroespes SA
MAD:EEP
|
3.9m EUR |
-35%
|
|
US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1T USD |
15%
|
|
US |
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
155.7B USD |
18%
|
|
US |
![]() |
Danaher Corp
NYSE:DHR
|
139.9B USD |
22%
|
|
KR |
![]() |
Samsung Biologics Co Ltd
KRX:207940
|
71.2T KRW |
32%
|
|
CH |
![]() |
Lonza Group AG
SIX:LONN
|
40.1B CHF |
18%
|
|
US |
![]() |
Agilent Technologies Inc
NYSE:A
|
32.3B USD |
24%
|
|
US |
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
24.8B USD |
15%
|
|
CN |
![]() |
WuXi AppTec Co Ltd
SSE:603259
|
176.3B CNY |
27%
|
|
US |
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
24B USD |
29%
|
|
FR |
![]() |
Sartorius Stedim Biotech SA
PAR:DIM
|
19.4B EUR |
14%
|
Euroespes SA
Glance View
EuroEspes SA engages in the provision of biomedical services. The company is headquartered in Bergondo, La Coruna. The company went IPO on 2012-06-21. The firm operates a medical center, which focuses on the prevention, diagnosis and treatment of central nervous system disorders, such as Alzheimer and Parkinson, and other common diseases. The Company’s medical offer includes personalized treatment plans, genomic medicine, epigenetics, neuropsychology, neuro-ophthalmology, digital diagnosis, diagnostic imaging, clinical analysis and nursing services, among others. In addition, it provides pharmacogenetics services and Human Identification Genetics card, which identifies user's deoxyribonucleic acid (DNA) profile. The firm operates through a number of subsidiaries, such as in Euroespes Biotecnologia SA, Distribuidora de Productos SL and Ebiotec Pharma SL.

See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Euroespes SA's most recent financial statements, the company has Operating Margin of -34.6%.